Ticarcillin

In some countries, this medicine may only be approved for veterinary use.

In the US, Ticarcillin (ticarcillin systemic) is a member of the drug class antipseudomonal penicillins and is used to treat Bone infection, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Septicemia, Skin Infection and Urinary Tract Infection.

US matches:

• Ticarcillin


• Ticarcillin/Clavulanate


• Ticarcillin and clavulanate potassium injection


• Ticarcillin and clavulanate Intravenous


• Ticarcillin Disodium and Clavulanate Potassium


• Ticarcillin/Clavulanate Potassium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01CA13

CAS registry number (Chemical Abstracts Service)

0034787-01-4

Chemical Formula

C15-H16-N2-O6-S2

Molecular Weight

384

Therapeutic Category

Antibacterial: Penicillin, broad-spectrum

Chemical Name

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxy-3-thienylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-[2α,5α,6ß(S*)]]-

Foreign Names

• Ticarcillinum (Latin)
• Ticarcillin (German)
• Ticarcilline (French)
• Ticarcilina (Spanish)

Generic Names

• Ticarcillin (OS: BAN)
• Ticarcillina (OS: DCIT)
• Ticarcilline (OS: DCF)
• Ticarcillin Disodium (OS: USAN)
• Ticarcillin Sodium (OS: BANM, JAN)
• BRL 2288 (IS: Beecham)
• Ticarcillin Disodium (PH: USP 32)
• Ticarcillin Sodium (PH: BP 2010, JP XIV, Ph. Eur. 6)
• Ticarcilline sodique (PH: Ph. Eur. 6)
• Ticarcillin-Natrium (PH: Ph. Eur. 6)
• Ticarcillinum natricum (PH: Ph. Eur. 6)

Brand Names

• Ticarpen
  GlaxoSmithKline, Tunisia



• Claventin (Ticarcillin and Clavulanic Acid)
  GlaxoSmithKline, France



• Ticarpen
  GlaxoSmithKline, France; SmithKline Beecham, Spain



• Ticillin (veterinary use)
  Pfizer Animal Health, United States



• Timentin (Ticarcillin and Clavulanic Acid potassium salt)
  GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Canada; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Italy; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.